Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".

Literature DB >> 34529464

Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".

Anne Puel^1,2,3,4, Jean-Laurent Casanova^1,2,3,4.

Abstract

Break et al. (Research Articles, 15 January 2021, eaay5731) suggest that chronic mucocutaneous candidiasis in humans with inborn errors of AIRE and autoimmune polyendocrine syndrome type 1 is due to excessive interferon-γ production and not to autoantibodies neutralizing interleukin-17 cytokines. We argue that both claims are not conclusively supported by their data and are at odds with 35 years of study.

Entities: Chemical

Mesh：

Year: 2021 PMID： 34529464 PMCID： PMC8509635 DOI： 10.1126/science.abi5459

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

15 in total

1. JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome.

Authors: Kate L Del Bel; Robert J Ragotte; Aabida Saferali; Susan Lee; Suzanne M Vercauteren; Sara A Mostafavi; Richard A Schreiber; Julie S Prendiville; Min S Phang; Jessica Halparin; Nicholas Au; John M Dean; John J Priatel; Emily Jewels; Anne K Junker; Paul C Rogers; Michael Seear; Margaret L McKinnon; Stuart E Turvey
Journal: J Allergy Clin Immunol Date: 2017-01-19 Impact factor: 10.793

2. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.

Authors: C F Nathan; G Kaplan; W R Levis; A Nusrat; M D Witmer; S A Sherwin; C K Job; C R Horowitz; R M Steinman; Z A Cohn
Journal: N Engl J Med Date: 1986-07-03 Impact factor: 91.245

Review 3. Autoimmune Polyendocrine Syndromes.

Authors: Eystein S Husebye; Mark S Anderson; Olle Kämpe
Journal: N Engl J Med Date: 2018-03-22 Impact factor: 91.245

4. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.

Authors: Y Ohyama; S Nakamura; G Matsuzaki; M Shinohara; A Hiroki; T Fujimura; A Yamada; K Itoh; K Nomoto
Journal: Arthritis Rheum Date: 1996-08

5. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.

Authors: Anne Puel; Rainer Döffinger; Angels Natividad; Maya Chrabieh; Gabriela Barcenas-Morales; Capucine Picard; Aurélie Cobat; Marie Ouachée-Chardin; Antoine Toulon; Jacinta Bustamante; Saleh Al-Muhsen; Mohammed Al-Owain; Peter D Arkwright; Colm Costigan; Vivienne McConnell; Andrew J Cant; Mario Abinun; Michel Polak; Pierre-François Bougnères; Dinakantha Kumararatne; László Marodi; Amit Nahum; Chaim Roifman; Stéphane Blanche; Alain Fischer; Christine Bodemer; Laurent Abel; Desa Lilic; Jean-Laurent Casanova
Journal: J Exp Med Date: 2010-02-01 Impact factor: 14.307

6. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults.

Authors: K Akashi; S Hayashi; H Gondo; S Mizuno; M Harada; K Tamura; K Yamasaki; T Shibuya; N Uike; T Okamura
Journal: Br J Haematol Date: 1994-06 Impact factor: 6.998

7. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.

Authors: Timothy J Break; Vasileios Oikonomou; Nicolas Dutzan; Jigar V Desai; Marc Swidergall; Tilo Freiwald; Daniel Chauss; Oliver J Harrison; Julie Alejo; Drake W Williams; Stefania Pittaluga; Chyi-Chia R Lee; Nicolas Bouladoux; Muthulekha Swamydas; Kevin W Hoffman; Teresa Greenwell-Wild; Vincent M Bruno; Lindsey B Rosen; Wint Lwin; Andy Renteria; Sergio M Pontejo; John P Shannon; Ian A Myles; Peter Olbrich; Elise M N Ferré; Monica Schmitt; Daniel Martin; Daniel L Barber; Norma V Solis; Luigi D Notarangelo; David V Serreze; Mitsuru Matsumoto; Heather D Hickman; Philip M Murphy; Mark S Anderson; Jean K Lim; Steven M Holland; Scott G Filler; Behdad Afzali; Yasmine Belkaid; Niki M Moutsopoulos; Michail S Lionakis
Journal: Science Date: 2021-01-15 Impact factor: 47.728

8. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.

Authors: Luyan Liu; Satoshi Okada; Xiao-Fei Kong; Alexandra Y Kreins; Sophie Cypowyj; Avinash Abhyankar; Julie Toubiana; Yuval Itan; Magali Audry; Patrick Nitschke; Cécile Masson; Beata Toth; Jérome Flatot; Mélanie Migaud; Maya Chrabieh; Tatiana Kochetkov; Alexandre Bolze; Alessandro Borghesi; Antoine Toulon; Julia Hiller; Stefanie Eyerich; Kilian Eyerich; Vera Gulácsy; Ludmyla Chernyshova; Viktor Chernyshov; Anastasia Bondarenko; Rosa María Cortés Grimaldo; Lizbeth Blancas-Galicia; Ileana Maria Madrigal Beas; Joachim Roesler; Klaus Magdorf; Dan Engelhard; Caroline Thumerelle; Pierre-Régis Burgel; Miriam Hoernes; Barbara Drexel; Reinhard Seger; Theresia Kusuma; Annette F Jansson; Julie Sawalle-Belohradsky; Bernd Belohradsky; Emmanuelle Jouanguy; Jacinta Bustamante; Mélanie Bué; Nathan Karin; Gizi Wildbaum; Christine Bodemer; Olivier Lortholary; Alain Fischer; Stéphane Blanche; Saleh Al-Muhsen; Janine Reichenbach; Masao Kobayashi; Francisco Espinosa Rosales; Carlos Torres Lozano; Sara Sebnem Kilic; Matias Oleastro; Amos Etzioni; Claudia Traidl-Hoffmann; Ellen D Renner; Laurent Abel; Capucine Picard; László Maródi; Stéphanie Boisson-Dupuis; Anne Puel; Jean-Laurent Casanova
Journal: J Exp Med Date: 2011-07-04 Impact factor: 14.307

9. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Authors: Paul Bastard; Lindsey B Rosen; Qian Zhang; Eleftherios Michailidis; Hans-Heinrich Hoffmann; Yu Zhang; Karim Dorgham; Quentin Philippot; Jérémie Rosain; Vivien Béziat; Steven M Holland; Guy Gorochov; Emmanuelle Jouanguy; Charles M Rice; Aurélie Cobat; Luigi D Notarangelo; Laurent Abel; Helen C Su; Jean-Laurent Casanova; Jérémy Manry; Elana Shaw; Liis Haljasmägi; Pärt Peterson; Lazaro Lorenzo; Lucy Bizien; Sophie Trouillet-Assant; Kerry Dobbs; Adriana Almeida de Jesus; Alexandre Belot; Anne Kallaste; Emilie Catherinot; Yacine Tandjaoui-Lambiotte; Jeremie Le Pen; Gaspard Kerner; Benedetta Bigio; Yoann Seeleuthner; Rui Yang; Alexandre Bolze; András N Spaan; Ottavia M Delmonte; Michael S Abers; Alessandro Aiuti; Giorgio Casari; Vito Lampasona; Lorenzo Piemonti; Fabio Ciceri; Kaya Bilguvar; Richard P Lifton; Marc Vasse; David M Smadja; Mélanie Migaud; Jérome Hadjadj; Benjamin Terrier; Darragh Duffy; Lluis Quintana-Murci; Diederik van de Beek; Lucie Roussel; Donald C Vinh; Stuart G Tangye; Filomeen Haerynck; David Dalmau; Javier Martinez-Picado; Petter Brodin; Michel C Nussenzweig; Stéphanie Boisson-Dupuis; Carlos Rodríguez-Gallego; Guillaume Vogt; Trine H Mogensen; Andrew J Oler; Jingwen Gu; Peter D Burbelo; Jeffrey I Cohen; Andrea Biondi; Laura Rachele Bettini; Mariella D'Angio; Paolo Bonfanti; Patrick Rossignol; Julien Mayaux; Frédéric Rieux-Laucat; Eystein S Husebye; Francesca Fusco; Matilde Valeria Ursini; Luisa Imberti; Alessandra Sottini; Simone Paghera; Eugenia Quiros-Roldan; Camillo Rossi; Riccardo Castagnoli; Daniela Montagna; Amelia Licari; Gian Luigi Marseglia; Xavier Duval; Jade Ghosn; John S Tsang; Raphaela Goldbach-Mansky; Kai Kisand; Michail S Lionakis; Anne Puel; Shen-Ying Zhang
Journal: Science Date: 2020-09-24 Impact factor: 63.714

5 in total

Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".

1. JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome.

2. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.

Review 3. Autoimmune Polyendocrine Syndromes.

4. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome.

5. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.

6. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults.

7. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.

8. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.

9. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

Review 1. Infections in the monogenic autoimmune syndrome APECED.

Review 2. Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?

Review 3. Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly.

4. Human autoantibodies underlying infectious diseases.

Review 5. From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.